Duncan Williams Asset Management’s AbbVie ABBV Stock Holding History

Duncan Williams Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.09M	Sell	4,993 -23	-0.5%	-$5.1K	0.3%	48
2025 Q4	$1.09M	Sell	5,016 -124	-2%	-$28.2K	0.27%	52
2025 Q3	$1.19M	Buy	5,140 +160	+3%	+$32.6K	0.33%	47
2025 Q2	$924K	Buy	4,980 +47	+1%	+$8.73K	0.29%	56
2025 Q1	$1.03M	Buy	4,933 +73	+2%	+$14.2K	0.37%	50
2024 Q4	$864K	Buy	4,860 +600	+14%	+$110K	0.34%	52
2024 Q3	$841K	Buy	4,260 +2,454	+136%	+$458K	0.46%	40
2024 Q2	$310K	Buy	1,806 +21	+1%	+$3.48K	0.26%	55
2024 Q1	$325K	Buy	+1,785	New	+$308K	0.29%	55

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Duncan Williams Asset Management's ABBV Position: Q1 2026 in Review

Duncan Williams Asset Management reduced its AbbVie (ABBV) stake by 0.46% in Q1 2026, selling an estimated $5.1K and leaving 4,993 shares worth $1.09M. The position accounts for 0.3% of the portfolio, ranked #48.

Duncan Williams Asset Management first reported a position in ABBV in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.19M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Duncan Williams Asset Management held 4,993 shares of AbbVie worth $1.09M as of Q1 2026.
Duncan Williams Asset Management sold 23 AbbVie shares in Q1 2026, an estimated $5.1K.
AbbVie made up 0.3% of Duncan Williams Asset Management's portfolio in Q1 2026, its #48 holding.
Duncan Williams Asset Management first reported a position in AbbVie in Q1 2024 and has held it in 9 quarters since.
Duncan Williams Asset Management's AbbVie position peaked at $1.19M in Q3 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Duncan Williams Asset Management's 13F filing for Q1 2026, filed 5 May 2026.